Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

COVID-19 may cause a common type of hair loss called telogen effluvium.

COVID-19 can cause skin problems.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Some drugs may help treat both COVID-19 and radiation injury.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

Testosterone's effects on COVID-19 are unclear and need more research.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Skin problems like rashes and hair loss can help diagnose and predict COVID-19.

Long-COVID has diverse, long-term health impacts, especially in young people.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.